Biofrontera (BFRIW) Share-based Compensation (2021 - 2025)

Biofrontera's Share-based Compensation history runs 5 years deep, the most recent figure standing at $289000.0 for Q4 2025.

• In Q4 2025, Share-based Compensation fell 3.34% year-over-year to $289000.0; the TTM figure through Dec 2025 stood at $728000.0 (down 11.97% YoY), while the FY2025 annual figure was $951000.0, down 6.67% from the prior year.
• Share-based Compensation was $289000.0 for Q4 2025 at Biofrontera, up from $100000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $517000.0 in Q1 2022 to a low of $100000.0 in Q3 2022.
• Historically, Share-based Compensation has averaged $227235.3 across 5 years, with a median of $228000.0 in 2023.
• The sharpest annual moves came in 2022 and 2023: Share-based Compensation jumped 196.9% in 2022, then sank 75.0% in 2023.
• A 5-year view of Share-based Compensation shows it stood at $129000.0 in 2021, then surged by 196.9% to $383000.0 in 2022, then tumbled by 40.47% to $228000.0 in 2023, then soared by 31.14% to $299000.0 in 2024, then decreased by 3.34% to $289000.0 in 2025.
• The last three Share-based Compensation figures came in at $289000.0 (Q4 2025), $100000.0 (Q3 2025), and $100000.0 (Q2 2025), per Business Quant data.